首页> 美国卫生研究院文献>Internal Medicine >Successful Treatment of a Case of Late-onset Colitis after Umbilical Cord Transplantation with Metronidazole: A Case Report and Literature Review
【2h】

Successful Treatment of a Case of Late-onset Colitis after Umbilical Cord Transplantation with Metronidazole: A Case Report and Literature Review

机译:甲硝唑成功治疗脐带移植术后迟发性结肠炎:一例报道并文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diarrhea after hematopoietic stem cell transplantation (HSCT) can be life-threatening, and its etiology includes conditioning regimens, graft-versus-host disease (GVHD), infections, and transplantation-associated microangiopathy (iTAM). Cord colitis syndrome (CCS) has been described as a syndrome of culture-negative and antibiotic-responsive persistent watery and non-bloody diarrhea of uncertain pathogenesis and occurs in umbilical cord blood transplantation (UCBT) recipients. We encountered a case similar to CCS that developed severe watery diarrhea after UCBT without any signs of GVHD or infection and responded well to metronidazole (MNZ) treatment. Since CCS is very rare, we herein describe a case of MNZ-effective diarrhea after UCBT.
机译:造血干细胞移植(HSCT)后的腹泻可能会危及生命,其病因包括调理方案,移植物抗宿主病(GVHD),感染和移植相关的微血管病(iTAM)。脐带结肠炎综合征(CCS)已被描述为病原性不确定的培养阴性和抗生素反应性持续性水样和非血性腹泻的综合征,发生于脐带血移植(UCBT)受者。我们遇到了一个类似CCS的案例,该案例在UCBT后发生严重的水样腹泻,没有任何GVHD或感染迹象,并且对甲硝唑(MNZ)的治疗反应良好。由于CCS非常罕见,因此我们在此描述UCBT后发生MNZ有效腹泻的病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号